Effects of interleukin-1beta on the release of AVP, ANP, and ACTH, cardiovascular function and thermogenesis.
IL-1β 对 AVP、ANP 和 ACTH 释放、心血管功能和生热作用的影响。
基本信息
- 批准号:04454260
- 负责人:
- 金额:$ 3.46万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1992
- 资助国家:日本
- 起止时间:1992 至 1993
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1. Central effects of interleukin-1beta on blood pressure, thermogenesis and the release of vasopressin, ACTH and atrial natriuretic peptide. Interleukin 1-beta (IL-1beta) increased plasma vasopressin (AVP), ACTH and atrial natriuretic peptide (ANP). IL-1beta in the low dose (3-30 ng ・ 100g^<-1> ・ BW) increased body temperature (BT) and blood pressure (BP), but its high dose (150 ng ・ 100g^<-1> ・ BW) depressed them. Indomethacin, a cycloxygenase inhibitor, prevented the responses to IL-1beta except for increases in ANP release.2. Peripheral Effects of interleukin-1beta on blood pressure, themoregulation and the release of vasopressin, ACTH and atrial natriuretichormones. IL-1beta given iv stimulated the release of AVP, ACTH, and ANP and increased or decreased blood pressure and thermogenesis. Indomethacin attenuatted all these responses to IL-1beta except for increases in ANP.3. Effects of a nitric oxide synthase inhibitor (LNAME) on vasopressin and atrial natriuretic hormone releaase, thermogenesis and cardiovascular function in response to interleukin-1beta in rats. LNAME stimulted the release of AVP and ANP and body temperature and blood pressure. NO formed by IL-1beta may not have direct effects on the release of these hormones, and the regulation of body temperature, but decreased transiently blood pressure.4. Roles of atrial natriuretic peptide in an interleukin-1beta-induced natriuresis in conscious rats. IL-1beta brought about a natriuresis in accordance with increased plasma ANP and the specific ANP receptor antagonist "HS 142-1" prevented the natriuresis induced by IL-1beta, despite increased plasma ANP.
1.白细胞介素-1 β对血压、产热和血管加压素、促肾上腺皮质激素和心钠素释放的中枢作用白细胞介素1-β(IL-1 β)增加血浆加压素(AVP)、促肾上腺皮质激素(ACTH)和心钠素(ANP)。低剂量(3-30 ng ·100 g ^ · BW)IL-1 β<-1>可使体温(BT)和血压(BP)升高,而高剂量(150 ng ·100 g ^<-1>· BW)则使体温和血压降低。环氧化酶抑制剂吲哚美辛可抑制IL-1 β的反应,但增加ANP的释放.白细胞介素-1 β对血压、热调节和血管加压素、ACTH和心房利钠素释放的外周效应iv IL-1 β刺激AVP、ACTH和ANP的释放,升高或降低血压和产热。吲哚美辛减弱了IL-1 β对所有这些反应,但增加了ANP。一氧化氮合酶抑制剂(LNAME)对白细胞介素-1 β诱导的大鼠血管加压素和心钠素释放酶、产热和心血管功能的影响LNAME可促进AVP和ANP的释放,并增加体温和血压。IL-1 β形成的NO可能对这些激素的释放,以及体温的调节没有直接的作用,但具有一过性的降压作用.心房利钠肽在白细胞介素1 β诱导清醒大鼠尿钠排泄中的作用。IL-1 β引起的尿钠排泄与血浆心钠素水平的升高一致,而特异性心钠素受体拮抗剂HS 142-1则可阻止IL-1 β引起的尿钠排泄,尽管血浆心钠素水平升高。
项目成果
期刊论文数量(134)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tokihisa Kimura,et al.: "Plasma vasopressin and atrial natriuretic hormone levels in hypopituitarism with and without hydrocortisone treatments:responses to an acute water load" Acta Endocrinol.(Copenh). 126. 217-223 (1992)
Tokihisa Kimura 等人:“垂体功能减退症患者使用或不使用氢化可的松治疗时的血浆加压素和心房钠尿激素水平:对急性水负荷的反应”Acta Endocrinol。(Copenh)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kozo Ota,et al.: "Interaction of ANP with endothelin on cardiovascular,renal and endocrine function" Am.J.Physiol.262. E135-E141 (1992)
Kozo Ota 等人:“ANP 与内皮素对心血管、肾和内分泌功能的相互作用”Am.J.Physiol.262。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Masaru Shoji,et al.: "Impaired water diuresis in a patient with psudo-Bartter syndrome" Endocrinol.Jpon.39. 65-71 (1992)
Masaru Shoji 等人:“假 Bartter 综合征患者的水利尿功能受损”Endocrinol.Jpon.39。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tokihisa Kimura,et al.: "Central effects of interleukin-1 on blood pressure,thermogenesis,and the release of vasopressin,ACTH,and atrial natriuretic peptide" Ann.N.Y.Acad.Sci.330-345 (1993)
Tokihisa Kimura 等人:“白细胞介素 1 对血压、生热作用以及加压素、促肾上腺皮质激素和心房钠尿肽释放的中枢作用”Ann.N.Y.Acad.Sci.330-345 (1993)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kazuhisa Takeuchi,et al.: "A case of secondary aldosteronism similar to Bartter's syndrome with no abnormality in renal chloride reabsorption" Tohoku J.Exp.Med.169. 141-157 (1993)
Kazuhisa Takeuchi 等人:“类似于 Bartter 综合征的继发性醛固酮增多症,肾氯重吸收无异常”Tohoku J.Exp.Med.169。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KIMURA Tokihisa其他文献
KIMURA Tokihisa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KIMURA Tokihisa', 18)}}的其他基金
Central roles of GABA,glutamic acid decarboxylase (GAD) activity and mRNA GAD expression in the regulation of blood pressured and vasopressin release in sportaneous hypertensive rats (SHR)
GABA、谷氨酸脱羧酶 (GAD) 活性和 mRNA GAD 表达在运动性高血压大鼠 (SHR) 血压和加压素释放调节中的核心作用
- 批准号:
07457162 - 财政年份:1995
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The Central Effects of Gabanergic Neurons on Cardiovascular Function and Body Fluid Regulation.
加巴能神经元对心血管功能和体液调节的中枢作用。
- 批准号:
01570463 - 财政年份:1989
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
The central or peripheral effects of atrial natriuretic peptide on the renin-angiotensin-aldosterone system, vasopressin release, and renal functions.
心钠素对肾素-血管紧张素-醛固酮系统、加压素释放和肾功能的中枢或外周作用。
- 批准号:
60570380 - 财政年份:1985
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Say Yes to NO: The Next Generation Scaffolds with Localized and Sustained Nitric Oxide (NO) Delivery for Central Nervous System Regeneration
对“否”说“是”:具有局部和持续一氧化氮 (NO) 输送的下一代支架,用于中枢神经系统再生
- 批准号:
EP/X027198/2 - 财政年份:2024
- 资助金额:
$ 3.46万 - 项目类别:
Fellowship
Thermospheric Estimation and CHaracterization with Nitric Oxide (TECHNO)
使用一氧化氮进行热层估计和表征 (TECHNO)
- 批准号:
2343844 - 财政年份:2024
- 资助金额:
$ 3.46万 - 项目类别:
Standard Grant
Activation of human brown adipose tissue using food ingredients that enhance the bioavailability of nitric oxide
使用增强一氧化氮生物利用度的食品成分激活人体棕色脂肪组织
- 批准号:
23H03323 - 财政年份:2023
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Multicenter randomized crossover trial to evaluate the pr ompt hemodynamic effect of inhaled nitric oxide in cardi ogenic shock patients with percutaneous ventricular assi st device (SUPPORT-pVAD)
评估吸入一氧化氮对使用经皮心室辅助装置的心源性休克患者的即时血流动力学影响的多中心随机交叉试验 (SUPPORT-pVAD)
- 批准号:
23K15158 - 财政年份:2023
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Search for novel plant immune-priming compounds by simple screening system using nitric oxide
通过使用一氧化氮的简单筛选系统寻找新型植物免疫引发化合物
- 批准号:
23K19296 - 财政年份:2023
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Elucidation of Ciliary Motion Inhibition Mechanism by Nitric Oxide Using Humanized Cilia Mouse Model
使用人源化纤毛小鼠模型阐明一氧化氮抑制纤毛运动的机制
- 批准号:
23K19659 - 财政年份:2023
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Proposal of a metal complex catalyzing the direct decomposition of nitric oxide based on quantum chemistry calculations
基于量子化学计算提出催化一氧化氮直接分解的金属配合物
- 批准号:
22KJ2475 - 财政年份:2023
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Electrochemically Generated Inhaled Nitric Oxide (iNO) delivery via High Flow Nasal Cannula (HFNC)
通过高流量鼻插管 (HFNC) 输送电化学产生的吸入一氧化氮 (iNO)
- 批准号:
10637303 - 财政年份:2023
- 资助金额:
$ 3.46万 - 项目类别:
Response to Exercise and Nitric Oxide in PAD: the RESIST PAD Trial
PAD 对运动和一氧化氮的反应:RESIST PAD 试验
- 批准号:
10656845 - 财政年份:2023
- 资助金额:
$ 3.46万 - 项目类别:














{{item.name}}会员




